Join the club for FREE to access the whole archive and other member benefits.

Fitbit clears FDA to identify people with irregular heartbeats

17-Nov-2021

Key points from article :

Results of a massive, 455,000-person study point to Fitbit’s ability to detect atrial fibrillation (AFib).

Fitbit received FDA clearance for its AFib feature, which uses a built-in ECG sensor to detect potential arrhythmias.

Researchers carried out a large, virtual clinical trial using Fitbit to detect AFib compared to an ECG patch.

Roughly 1% of all participants got an irregular heart rhythm notification.

These people were instructed to use an ECG patch at home for a week; 32% were confirmed to have atrial fibrillation.

But it faces challenges with implementation, as many people failed to follow-up.

“We’re eager to find a way to engage participants in remote clinical research in the future,” - Steven Lubitz, study’s lead author.

The study had no control group, and no report on false negatives, or people who got no alert, but did have AFib.

Apple devices showed a potential interest to detect other types of arrhythmias.

Study by MGH presented at the American Heart Association’s Scientific Sessions.

Detected atrial fibrillation in one-third of adults, but faces issues with implementation

Mentioned in this article:

Tap on icon for description, click on resource name for more details.

Health Organisation

Largest teaching hospital of Harvard Medical School located in Boston

Academic

Cardiac Electrophysiologist at the Massachusetts General Hospital